Džudović, Jelena

Link to this page

Authority KeyName Variants
fb22749f-51f9-4880-9718-ae1c6b475adb
  • Džudović, Jelena (4)
Projects

Author's Bibliography

Development and validation of LC-MS/MS method for determination of plasma apixaban

Džudović, Jelena; Crevar-Sakač, Milkica; Antunović, Marko; Repić, Aleksandra; Obradović, Slobodan; Đorđević, Snežana; Savić, Jelena; Džudović, Boris

(Akademiai Kiado ZRt., 2022)

TY  - JOUR
AU  - Džudović, Jelena
AU  - Crevar-Sakač, Milkica
AU  - Antunović, Marko
AU  - Repić, Aleksandra
AU  - Obradović, Slobodan
AU  - Đorđević, Snežana
AU  - Savić, Jelena
AU  - Džudović, Boris
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4332
AB  - Oral anticoagulants are a group of drugs used for the prevention and treatment of venous thrombosis and venous thromboembolism. For the last ten years, direct oral anticoagulants (DOAC) have been available and are equally effective, but significantly safer than vitamin K antagonists. In the case of an overdose, their most important side effect is still bleeding. Due to their widespread use, as well as increased toxicological importance there is a need to develop an analytical method for the determination of DOAC in biological material. The aim of this paper was to establish a method for the quantification of apixaban as one of the representatives of DOAC. The methodology of the study included the measurement of apixaban in the plasma of patients treated in the intensive care unit. Plasma apixaban concentrations were determined by LC-MS/MS technique using carbamazepine as an internal standard. Obtained validation parameters indicate that the introduced method is sensitive, reliable, precise and accurate. Using this method, apixaban can be quickly and easily detected and quantified in plasma in patients who are suspected of overdosing with this drug.
PB  - Akademiai Kiado ZRt.
T2  - Acta Chromatographica
T1  - Development and validation of LC-MS/MS method for determination of plasma apixaban
VL  - 34
IS  - 3
SP  - 332
EP  - 337
DO  - 10.1556/1326.2021.00948
ER  - 
@article{
author = "Džudović, Jelena and Crevar-Sakač, Milkica and Antunović, Marko and Repić, Aleksandra and Obradović, Slobodan and Đorđević, Snežana and Savić, Jelena and Džudović, Boris",
year = "2022",
abstract = "Oral anticoagulants are a group of drugs used for the prevention and treatment of venous thrombosis and venous thromboembolism. For the last ten years, direct oral anticoagulants (DOAC) have been available and are equally effective, but significantly safer than vitamin K antagonists. In the case of an overdose, their most important side effect is still bleeding. Due to their widespread use, as well as increased toxicological importance there is a need to develop an analytical method for the determination of DOAC in biological material. The aim of this paper was to establish a method for the quantification of apixaban as one of the representatives of DOAC. The methodology of the study included the measurement of apixaban in the plasma of patients treated in the intensive care unit. Plasma apixaban concentrations were determined by LC-MS/MS technique using carbamazepine as an internal standard. Obtained validation parameters indicate that the introduced method is sensitive, reliable, precise and accurate. Using this method, apixaban can be quickly and easily detected and quantified in plasma in patients who are suspected of overdosing with this drug.",
publisher = "Akademiai Kiado ZRt.",
journal = "Acta Chromatographica",
title = "Development and validation of LC-MS/MS method for determination of plasma apixaban",
volume = "34",
number = "3",
pages = "332-337",
doi = "10.1556/1326.2021.00948"
}
Džudović, J., Crevar-Sakač, M., Antunović, M., Repić, A., Obradović, S., Đorđević, S., Savić, J.,& Džudović, B.. (2022). Development and validation of LC-MS/MS method for determination of plasma apixaban. in Acta Chromatographica
Akademiai Kiado ZRt.., 34(3), 332-337.
https://doi.org/10.1556/1326.2021.00948
Džudović J, Crevar-Sakač M, Antunović M, Repić A, Obradović S, Đorđević S, Savić J, Džudović B. Development and validation of LC-MS/MS method for determination of plasma apixaban. in Acta Chromatographica. 2022;34(3):332-337.
doi:10.1556/1326.2021.00948 .
Džudović, Jelena, Crevar-Sakač, Milkica, Antunović, Marko, Repić, Aleksandra, Obradović, Slobodan, Đorđević, Snežana, Savić, Jelena, Džudović, Boris, "Development and validation of LC-MS/MS method for determination of plasma apixaban" in Acta Chromatographica, 34, no. 3 (2022):332-337,
https://doi.org/10.1556/1326.2021.00948 . .
3
3

Development and validation of a rapid and simple UPLC/MS method for quantification of therapeutic and toxic valproic acid concentrations in patient plasma

Antunović, Marko; Đorđević, Snežana; Kilibarda, Vesna; Džudović, Jelena; Repić, Aleksandra; Bulat, Zorica

(Savez farmaceutskih udruženja Srbije (SFUS), 2022)

TY  - JOUR
AU  - Antunović, Marko
AU  - Đorđević, Snežana
AU  - Kilibarda, Vesna
AU  - Džudović, Jelena
AU  - Repić, Aleksandra
AU  - Bulat, Zorica
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4498
AB  - Valproic acid (VPA) is antiepileptic drug with a long history of clinical use,
increasingly applied in the treatment of various diseases (bipolar disorder, migraine
prophylaxis, etc). Due to significant inter-individual differences VPA concentration is often
measured in the purpose of therapeutic drug monitoring (TDM) (1). Acute poisonings with
this drug represent a significant problem. According to the American Association of Poison
Control Centers, there has been VPA poisoning incidence increase in the last 20 years.
Reports from the National Poison Control Center in Belgrade list VPA as one of the three
most common causes of antiepileptic drugs intoxications (2). This paper aimed to develop a
modern analytical method for VPA quantification in patient plasma. UPLC/MS method with
fast and simple sample preparation has been validated. After protein precipitation, VPA was
extracted from 100 μL plasma using HLB cartridges. Caprylic acid solution was used as
internal standard. Chromatographic separation was achieved on C18 column (1.8 μm, 2.1 X
150 mm) with gradient elution at constant mobile phase flow. Good peak resolution was
achieved (Rt VPA - 4.73 min, Rt ISTD - 4.94 min). Validation was performed according European
Medicines Agency recommendations. Based on statistical analysism it was shown that the
method is precise, accurate, specific, sensitive and linearity is confirmed in a wide range of
concentrations (1-250 mg / L). Advantages of this method are simple preparation procedure
from a small amount of sample, without prior derivatization and short duration of analysis,
which fully satisfies the needs of TDM and urgent toxicological analyses.
AB  - Valproinska kiselina (VK) je lek iz grupe antiepileptika sa dugom istorijom kliničke
upotrebe, koji se, osim u terapiji epilepsije, poslednjih decenija sve više koristi u terapiji
različitih bolesti (bipolarni poremećaj, profilaksa migrene itd). Zbog značajnih
interindividualnih varijacija, koncentracija VK se često određuje u svrhe terapijskog praćenja
leka (TDM – Therapeutic Drug Monitoring) (1). S druge strane, akutna trovanja ovim lekom
predstavljaju značajan problem. Prema podacima Američkih centara za kontrolu trovanja
došlo je do povećanja incidence trovanja VK u poslednjih 20 godina, dok izveštaji
Nacionalnog centra za kontrolu trovanja u Beogradu navode VK kao jedan od tri najčešća
uzročnika trovanja kada su u pitanju intoksikacije antiepilepticima (2). Cilj ovoga rada je
razvoj savremene analitičke metode za određivanje koncentracije VK u plazmi pacijenata.
Validovana je UPLC/MS metoda koja podrazumeva brzu i jednostavnu pripremu uzorka.
Nakon precipitacije proteina, izvršena je ekstrakcija iz 100 μL plazme uz pomoć HLB
kertridža. Kao interni standard korišćen je rastvor kaprilne kiseline. Hromatografsko
razdvajanje je postignuto na C18 koloni (1,8 μm, 2,1 X 150 mm) gradijentnim eluiranjem pri
konstantnom protoku mobilne faze. Postignuta je dobra rezolucija pikova (Rt VK - 4,73 min,
Rt ISTD - 4,94 min). Validacija je izvedena prema preporukama Evropske agencije za lekove, a
na osnovu statističke analize je pokazano da je metoda precizna, tačna, specifična, osetljiva i
potvrđena je linearnost u širokom opsegu koncentracija (1-250 mg/L). Prednosti ove
metode su jednostavan način pripreme iz male količine uzorka, bez prethodne derivatizacije,
i kratko vreme trajanja analize, što u potpunosti zadovoljava potrebe TDM-a i urgentnih
toksikoloških analiza.
PB  - Savez farmaceutskih udruženja Srbije (SFUS)
T2  - Arhiv za farmaciju
T1  - Development and validation of a rapid and simple UPLC/MS method for quantification of therapeutic and toxic valproic acid concentrations in patient plasma
T1  - Razvoj i validacija brze i jednostavne UPLC/MS metode za određivanje terapijskih i toksičnih koncentracija valproinske kiseline u plazmi pacijenata
VL  - 72
IS  - 4 suplement
SP  - S215
EP  - S216
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4498
ER  - 
@article{
author = "Antunović, Marko and Đorđević, Snežana and Kilibarda, Vesna and Džudović, Jelena and Repić, Aleksandra and Bulat, Zorica",
year = "2022",
abstract = "Valproic acid (VPA) is antiepileptic drug with a long history of clinical use,
increasingly applied in the treatment of various diseases (bipolar disorder, migraine
prophylaxis, etc). Due to significant inter-individual differences VPA concentration is often
measured in the purpose of therapeutic drug monitoring (TDM) (1). Acute poisonings with
this drug represent a significant problem. According to the American Association of Poison
Control Centers, there has been VPA poisoning incidence increase in the last 20 years.
Reports from the National Poison Control Center in Belgrade list VPA as one of the three
most common causes of antiepileptic drugs intoxications (2). This paper aimed to develop a
modern analytical method for VPA quantification in patient plasma. UPLC/MS method with
fast and simple sample preparation has been validated. After protein precipitation, VPA was
extracted from 100 μL plasma using HLB cartridges. Caprylic acid solution was used as
internal standard. Chromatographic separation was achieved on C18 column (1.8 μm, 2.1 X
150 mm) with gradient elution at constant mobile phase flow. Good peak resolution was
achieved (Rt VPA - 4.73 min, Rt ISTD - 4.94 min). Validation was performed according European
Medicines Agency recommendations. Based on statistical analysism it was shown that the
method is precise, accurate, specific, sensitive and linearity is confirmed in a wide range of
concentrations (1-250 mg / L). Advantages of this method are simple preparation procedure
from a small amount of sample, without prior derivatization and short duration of analysis,
which fully satisfies the needs of TDM and urgent toxicological analyses., Valproinska kiselina (VK) je lek iz grupe antiepileptika sa dugom istorijom kliničke
upotrebe, koji se, osim u terapiji epilepsije, poslednjih decenija sve više koristi u terapiji
različitih bolesti (bipolarni poremećaj, profilaksa migrene itd). Zbog značajnih
interindividualnih varijacija, koncentracija VK se često određuje u svrhe terapijskog praćenja
leka (TDM – Therapeutic Drug Monitoring) (1). S druge strane, akutna trovanja ovim lekom
predstavljaju značajan problem. Prema podacima Američkih centara za kontrolu trovanja
došlo je do povećanja incidence trovanja VK u poslednjih 20 godina, dok izveštaji
Nacionalnog centra za kontrolu trovanja u Beogradu navode VK kao jedan od tri najčešća
uzročnika trovanja kada su u pitanju intoksikacije antiepilepticima (2). Cilj ovoga rada je
razvoj savremene analitičke metode za određivanje koncentracije VK u plazmi pacijenata.
Validovana je UPLC/MS metoda koja podrazumeva brzu i jednostavnu pripremu uzorka.
Nakon precipitacije proteina, izvršena je ekstrakcija iz 100 μL plazme uz pomoć HLB
kertridža. Kao interni standard korišćen je rastvor kaprilne kiseline. Hromatografsko
razdvajanje je postignuto na C18 koloni (1,8 μm, 2,1 X 150 mm) gradijentnim eluiranjem pri
konstantnom protoku mobilne faze. Postignuta je dobra rezolucija pikova (Rt VK - 4,73 min,
Rt ISTD - 4,94 min). Validacija je izvedena prema preporukama Evropske agencije za lekove, a
na osnovu statističke analize je pokazano da je metoda precizna, tačna, specifična, osetljiva i
potvrđena je linearnost u širokom opsegu koncentracija (1-250 mg/L). Prednosti ove
metode su jednostavan način pripreme iz male količine uzorka, bez prethodne derivatizacije,
i kratko vreme trajanja analize, što u potpunosti zadovoljava potrebe TDM-a i urgentnih
toksikoloških analiza.",
publisher = "Savez farmaceutskih udruženja Srbije (SFUS)",
journal = "Arhiv za farmaciju",
title = "Development and validation of a rapid and simple UPLC/MS method for quantification of therapeutic and toxic valproic acid concentrations in patient plasma, Razvoj i validacija brze i jednostavne UPLC/MS metode za određivanje terapijskih i toksičnih koncentracija valproinske kiseline u plazmi pacijenata",
volume = "72",
number = "4 suplement",
pages = "S215-S216",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4498"
}
Antunović, M., Đorđević, S., Kilibarda, V., Džudović, J., Repić, A.,& Bulat, Z.. (2022). Development and validation of a rapid and simple UPLC/MS method for quantification of therapeutic and toxic valproic acid concentrations in patient plasma. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije (SFUS)., 72(4 suplement), S215-S216.
https://hdl.handle.net/21.15107/rcub_farfar_4498
Antunović M, Đorđević S, Kilibarda V, Džudović J, Repić A, Bulat Z. Development and validation of a rapid and simple UPLC/MS method for quantification of therapeutic and toxic valproic acid concentrations in patient plasma. in Arhiv za farmaciju. 2022;72(4 suplement):S215-S216.
https://hdl.handle.net/21.15107/rcub_farfar_4498 .
Antunović, Marko, Đorđević, Snežana, Kilibarda, Vesna, Džudović, Jelena, Repić, Aleksandra, Bulat, Zorica, "Development and validation of a rapid and simple UPLC/MS method for quantification of therapeutic and toxic valproic acid concentrations in patient plasma" in Arhiv za farmaciju, 72, no. 4 suplement (2022):S215-S216,
https://hdl.handle.net/21.15107/rcub_farfar_4498 .

Development and validation of liquid chromatography tandem mass spectrometry method for determination of rivaroxaban in plasma samples

Miličević, Maja; Crevar, Milkica; Ivković, Branka; Džudović, Jelena

(Savez farmaceutskih udruženja Srbije (SFUS), 2022)

TY  - CONF
AU  - Miličević, Maja
AU  - Crevar, Milkica
AU  - Ivković, Branka
AU  - Džudović, Jelena
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4599
AB  - Rivaroxaban belongs to the group of direct oral anticoagulants (DOAC), drugs used to
prevent and treat venous thrombosis and venous thromboembolism. Drugs from this group
are considered safer than vitamin K antagonists. In case of overdose, their most significant
side effect is bleeding. Given the great toxicological significance, it is very important to
develop an analytical method for quantification of this drug in biological samples. The liquid
chromatography-tandem mass spectrometry (LC-MS/MS) method for the determination of
rivaroxaban content in plasma samples was optimized and validated. Plasma samples were
prepared by protein precipitation with cold acetonitrile. Carbamazepine was used as an
internal standard. The analysis was performed on an Infinity Lab Poroshell 120 EC-C18, 4.6
×100 mm, 2.7 μm chromatographic column. The mobile phase consisted of acetonitrile and
0.1% formic acid (50:50, v/v), at a flow rate of 400 μL/min and a column temperature set at
30°C. The autosampler temperature was 4C. The injection volume was 10 μL. Detection of
analytes and internal standard was performed in multireaction monitoring mode (MRM), at
the following ion transitions: 437>145 (m/z) for rivaroxaban, and 237>194 (m/z) for the
internal standard. The optimized method was validated and the obtained parameters
indicate that the method is sensitive, specific, selective, precise and accurate. The samples
were stable under the tested conditions. A validated method has been used to determine the
concentration of rivaroxaban in plasma samples of patients with atrial fibrillation who were
hospitalized under strict medical supervision. Obtained concentrations were in the expected
range.
AB  - Rivaroksaban pripada grupi direktnih oralnih antikoagulanasa (DOAK), lekova koji se
koriste za prevenciju i lečenje venske tromboze i venske tromboembolije. Lekovi iz ove
grupe se smatraju bezbednijim od antagonista vitamina K. U slučaju predoziranja, njihov
najznačajniji neželjeni efekat je krvarenje. S obzirom na veliki toksikološki značaj, veoma je
važno postojanje analitičke metode za određivanje sadržaja ovog leka u uzorcima biološkog
materijala. Optimizovana je i validirana metoda tečne hromatografije spregnute sa masenom
spektrometrijom (LC-MS/MS) za određivanje sadržaja rivaroksabana u uzorcima plazme.
Uzorci plazme su pripremani metodom precipitacije proteina koja je vršena hladnim
acetonitrilom. Kao interni standard korišćen je karbamazepin. Analiza je izvršena na Infinity
Lab Poroshell 120 EC-C18, 4,6×100 mm, 2,7 μm hromatografskoj koloni. Mobilna faza se
sastojala od acetonitrila i 0,1% mravlje kiseline (50:50, v/v), pri protoku od 400 μL/min i
temperaturi kolone podešenoj na 30°C. Temperatura autosemplera je bila 4C. Injekciona
zapremina je bila 10 μL. Detekcija analita i internog standarda je izvršena u multireakcionom
monitoring modu (MRM), pri sledećim jonskim prelazima: 437>145 (m/z) za rivaroksaban,
odnosno 237>194 (m/z) za interni standard. Optimizovana metoda je validirana i dobijeni
parametri ukazuju da je metoda osetljiva, specifična, selektivna, precizna i tačna. Uzorci su
stabilni pri ispitivanim uslovima. Validirana metoda je primenjena za određivanje
koncentracije rivaroksabana u uzorcima plazme pacijenata sa atrijalnom fibrilacijom, koji su
bili hospitalizovani, pod strogim medicinskim nadzorom. Određene koncentracije su bile u
očekivanom opsegu.
PB  - Savez farmaceutskih udruženja Srbije (SFUS)
C3  - Arhiv za farmaciju
T1  - Development and validation of liquid chromatography tandem mass spectrometry method for determination of rivaroxaban in plasma samples
T1  - Razvoj i validacija metode tečne hromatografije spregnute sa masenom spektrometrijom za određivanje sadržaja rivaroksabana u uzorcima plazme
VL  - 72
IS  - 4 suplement
SP  - S534
EP  - S535
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4599
ER  - 
@conference{
author = "Miličević, Maja and Crevar, Milkica and Ivković, Branka and Džudović, Jelena",
year = "2022",
abstract = "Rivaroxaban belongs to the group of direct oral anticoagulants (DOAC), drugs used to
prevent and treat venous thrombosis and venous thromboembolism. Drugs from this group
are considered safer than vitamin K antagonists. In case of overdose, their most significant
side effect is bleeding. Given the great toxicological significance, it is very important to
develop an analytical method for quantification of this drug in biological samples. The liquid
chromatography-tandem mass spectrometry (LC-MS/MS) method for the determination of
rivaroxaban content in plasma samples was optimized and validated. Plasma samples were
prepared by protein precipitation with cold acetonitrile. Carbamazepine was used as an
internal standard. The analysis was performed on an Infinity Lab Poroshell 120 EC-C18, 4.6
×100 mm, 2.7 μm chromatographic column. The mobile phase consisted of acetonitrile and
0.1% formic acid (50:50, v/v), at a flow rate of 400 μL/min and a column temperature set at
30°C. The autosampler temperature was 4C. The injection volume was 10 μL. Detection of
analytes and internal standard was performed in multireaction monitoring mode (MRM), at
the following ion transitions: 437>145 (m/z) for rivaroxaban, and 237>194 (m/z) for the
internal standard. The optimized method was validated and the obtained parameters
indicate that the method is sensitive, specific, selective, precise and accurate. The samples
were stable under the tested conditions. A validated method has been used to determine the
concentration of rivaroxaban in plasma samples of patients with atrial fibrillation who were
hospitalized under strict medical supervision. Obtained concentrations were in the expected
range., Rivaroksaban pripada grupi direktnih oralnih antikoagulanasa (DOAK), lekova koji se
koriste za prevenciju i lečenje venske tromboze i venske tromboembolije. Lekovi iz ove
grupe se smatraju bezbednijim od antagonista vitamina K. U slučaju predoziranja, njihov
najznačajniji neželjeni efekat je krvarenje. S obzirom na veliki toksikološki značaj, veoma je
važno postojanje analitičke metode za određivanje sadržaja ovog leka u uzorcima biološkog
materijala. Optimizovana je i validirana metoda tečne hromatografije spregnute sa masenom
spektrometrijom (LC-MS/MS) za određivanje sadržaja rivaroksabana u uzorcima plazme.
Uzorci plazme su pripremani metodom precipitacije proteina koja je vršena hladnim
acetonitrilom. Kao interni standard korišćen je karbamazepin. Analiza je izvršena na Infinity
Lab Poroshell 120 EC-C18, 4,6×100 mm, 2,7 μm hromatografskoj koloni. Mobilna faza se
sastojala od acetonitrila i 0,1% mravlje kiseline (50:50, v/v), pri protoku od 400 μL/min i
temperaturi kolone podešenoj na 30°C. Temperatura autosemplera je bila 4C. Injekciona
zapremina je bila 10 μL. Detekcija analita i internog standarda je izvršena u multireakcionom
monitoring modu (MRM), pri sledećim jonskim prelazima: 437>145 (m/z) za rivaroksaban,
odnosno 237>194 (m/z) za interni standard. Optimizovana metoda je validirana i dobijeni
parametri ukazuju da je metoda osetljiva, specifična, selektivna, precizna i tačna. Uzorci su
stabilni pri ispitivanim uslovima. Validirana metoda je primenjena za određivanje
koncentracije rivaroksabana u uzorcima plazme pacijenata sa atrijalnom fibrilacijom, koji su
bili hospitalizovani, pod strogim medicinskim nadzorom. Određene koncentracije su bile u
očekivanom opsegu.",
publisher = "Savez farmaceutskih udruženja Srbije (SFUS)",
journal = "Arhiv za farmaciju",
title = "Development and validation of liquid chromatography tandem mass spectrometry method for determination of rivaroxaban in plasma samples, Razvoj i validacija metode tečne hromatografije spregnute sa masenom spektrometrijom za određivanje sadržaja rivaroksabana u uzorcima plazme",
volume = "72",
number = "4 suplement",
pages = "S534-S535",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4599"
}
Miličević, M., Crevar, M., Ivković, B.,& Džudović, J.. (2022). Development and validation of liquid chromatography tandem mass spectrometry method for determination of rivaroxaban in plasma samples. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije (SFUS)., 72(4 suplement), S534-S535.
https://hdl.handle.net/21.15107/rcub_farfar_4599
Miličević M, Crevar M, Ivković B, Džudović J. Development and validation of liquid chromatography tandem mass spectrometry method for determination of rivaroxaban in plasma samples. in Arhiv za farmaciju. 2022;72(4 suplement):S534-S535.
https://hdl.handle.net/21.15107/rcub_farfar_4599 .
Miličević, Maja, Crevar, Milkica, Ivković, Branka, Džudović, Jelena, "Development and validation of liquid chromatography tandem mass spectrometry method for determination of rivaroxaban in plasma samples" in Arhiv za farmaciju, 72, no. 4 suplement (2022):S534-S535,
https://hdl.handle.net/21.15107/rcub_farfar_4599 .

The influence of smoking habits on cadmium and lead blood levels in the Serbian adult people

Repić, Aleksandra; Bulat, Petar; Antonijević, Biljana; Antunović, Marko; Džudović, Jelena; Buha, Aleksandra; Bulat, Zorica

(Springer-Verlag GmbH Germany, part of Springer Nature, 2020)

TY  - JOUR
AU  - Repić, Aleksandra
AU  - Bulat, Petar
AU  - Antonijević, Biljana
AU  - Antunović, Marko
AU  - Džudović, Jelena
AU  - Buha, Aleksandra
AU  - Bulat, Zorica
PY  - 2020
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3486
AB  - According to theWorld Health Organization, in 2015, the Serbian population ranked among the highest ones in Europe in terms of smoking habit: 44.3%males and 36.2%females aged 18–64 smoked tobacco. In the last 7 years, 25%of total mortality inmen and 9%in women from Serbia were associated with smoking. Tobacco smoking is one of the most important sources of exposure to many toxic substances in general population. Our study confirmed higher blood levels of two toxic metals, cadmium and lead, in the blood of smokers (3.5 and 1.5 times higher than in non-smokers, respectively). Furthermore, smoking habits, such as number of smoked cigarettes per day, smoking period and cigarette type, along with age, were shown to influence these metals’ blood concentration. Higher blood levels of Cd and Pb were found in smokers consuming more than 10 cigarettes per day for more than 10 years. The present study also highlighted the importance of the controlled tobacco production, since it was shown that consumption of illicit tobacco could manifold the exposure to toxic metals that can subsequently increase the frequency of related diseases as well.
PB  - Springer-Verlag GmbH Germany, part of Springer Nature
T2  - Environmental Science and Pollution Research
T1  - The influence of smoking habits on cadmium and lead blood levels in the Serbian adult people
VL  - 27
SP  - 751
EP  - 760
DO  - 10.1007/s11356-019-06840-1
ER  - 
@article{
author = "Repić, Aleksandra and Bulat, Petar and Antonijević, Biljana and Antunović, Marko and Džudović, Jelena and Buha, Aleksandra and Bulat, Zorica",
year = "2020",
abstract = "According to theWorld Health Organization, in 2015, the Serbian population ranked among the highest ones in Europe in terms of smoking habit: 44.3%males and 36.2%females aged 18–64 smoked tobacco. In the last 7 years, 25%of total mortality inmen and 9%in women from Serbia were associated with smoking. Tobacco smoking is one of the most important sources of exposure to many toxic substances in general population. Our study confirmed higher blood levels of two toxic metals, cadmium and lead, in the blood of smokers (3.5 and 1.5 times higher than in non-smokers, respectively). Furthermore, smoking habits, such as number of smoked cigarettes per day, smoking period and cigarette type, along with age, were shown to influence these metals’ blood concentration. Higher blood levels of Cd and Pb were found in smokers consuming more than 10 cigarettes per day for more than 10 years. The present study also highlighted the importance of the controlled tobacco production, since it was shown that consumption of illicit tobacco could manifold the exposure to toxic metals that can subsequently increase the frequency of related diseases as well.",
publisher = "Springer-Verlag GmbH Germany, part of Springer Nature",
journal = "Environmental Science and Pollution Research",
title = "The influence of smoking habits on cadmium and lead blood levels in the Serbian adult people",
volume = "27",
pages = "751-760",
doi = "10.1007/s11356-019-06840-1"
}
Repić, A., Bulat, P., Antonijević, B., Antunović, M., Džudović, J., Buha, A.,& Bulat, Z.. (2020). The influence of smoking habits on cadmium and lead blood levels in the Serbian adult people. in Environmental Science and Pollution Research
Springer-Verlag GmbH Germany, part of Springer Nature., 27, 751-760.
https://doi.org/10.1007/s11356-019-06840-1
Repić A, Bulat P, Antonijević B, Antunović M, Džudović J, Buha A, Bulat Z. The influence of smoking habits on cadmium and lead blood levels in the Serbian adult people. in Environmental Science and Pollution Research. 2020;27:751-760.
doi:10.1007/s11356-019-06840-1 .
Repić, Aleksandra, Bulat, Petar, Antonijević, Biljana, Antunović, Marko, Džudović, Jelena, Buha, Aleksandra, Bulat, Zorica, "The influence of smoking habits on cadmium and lead blood levels in the Serbian adult people" in Environmental Science and Pollution Research, 27 (2020):751-760,
https://doi.org/10.1007/s11356-019-06840-1 . .
1
36
10
29